Reneo Pharmaceuticals

12/07/2023

SuspectPMM.com is here. Learn more about PMM and how genetic testing can help your patients get closer to a diagnosis.
https://www.suspectpmm.com/

Patients with primary mitochondrial myopathies (PMM) can spend years without receiving diagnostic clarity.

11/27/2023

Reneo will be attending the Piper Sandler 35th Annual Healthcare Conference. Don’t miss your chance to meet our team in New York.

👤 Piper’s Biotech Analyst, RPHM covering analyst, Yasmeen Rahimi, PhD, will host our fireside chat!

📅 November 28

📍 The Lotte New York Palace

11/23/2023

On this , we are grateful for our team and the community that inspires us. We wish everyone a happy holiday surrounded by the loved ones.

11/13/2023

Reneo reports 3Q 2023 financial results and anticipates the topline results from the pivotal STRIDE study in December 2023.

For more information, follow the link -> https://bit.ly/46cHvxe

11/09/2023

In honor of Genetic Counselor Awareness Day on November 9th, Reneo would like to express our gratitude for the significant work genetic counselors do in supporting patients with rare diseases, including mitochondrial disease!

11/03/2023

Reneo’s Wendy Johnson, Chief Business Officer, is attending in Munich on November 6-8. $RPHM

Learn more about the conference at https://bit.ly/46ODksN

11/03/2023

Save the date! On November 6, Bianca Seminotti, PhD, Research Scientist at UPMC Children's Hospital of Pittsburgh, will attend TRiMAD conference in Pittsburg and present scientific data on effects in fibroblasts from patients with complex I deficiency.

For more details -> https://www.globenewswire.com/news-release/2023/10/25/2766415/0/en/Reneo-Pharmaceuticals-Announces-Poster-Presentation-at-Upcoming-Scientific-Meetings.html

11/02/2023

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences. $RPHM

For more information, follow the link https://bit.ly/46TFU0N

11/01/2023

Our team, Carson Harrod, PhD, Director of Medical Affairs Operations and Kurt Grady, PharmD, MBA, Head, US Medical Science Liaisons, will be in Arizona on November 1-4 attending the 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting. We look forward to engaging in stimulating discussions, workshops, and networking!

10/31/2023

We are excited to welcome Shareh Jahangiri to team Reneo, where she will serve as an Executive Director, Head of Quality Assurance.

10/30/2023

– check out the recent interview featuring our CEO, Gregory Flesher and Jane King of NASDAQ Innovators Segment, who engage in a stimulating discussion about the rare disease space, the company’s drug candidate and more.

You don’t want to miss it

Jane King interviews Gregory Flesher, President & Chief Executive Officer, Reneo Pharmaceuticals (NASDAQ: RPHM). https://reneopharma.comInnovators with Jane ...

10/27/2023

Watch the conversation between our CEO, Gregory J. Flesher and Jane King of Nasdaq Innovators Segment discussing Reneo’s approach to unmet medical need for rare .

Interview-> https://lnkd.in/gH2yQg8Y

Also aired on KRON4News tomorrow https://www.kron4.com/